NVDIAG participated in the 12th Annual AIS Conference

In June 2024, representatives from we had the opportunity to participate in the 12th Antibody Industrial Symposium 2024 (AIS2024), a leading conference for scientists, industry professionals, physicians, and policymakers. This event served as the ideal platform to discuss cutting-edge topics in therapeutic antibodies, recombinant proteins, and cellular immunotherapy, from research and development to clinical application.

During the symposium, we engaged in valuable exchanges with experts from across the globe, sharing insights and exploring the latest advancements in the field. Their participation highlighted the LabCom’s commitment to staying at the forefront of innovation and collaboration within the biotechnology and healthcare sectors.

We are proud of the team’s contributions and look forward to the continued advancements and partnerships resulting from this exciting event.

More info about the 12th Annual AIS Conference